EPG Online Twitter
EPG Online Blog
Disease Knowledge
Drug Updates
Cancer patients receiving drugs to lower the risk of anaemia may be...
Published Tuesday 01 December 2009
Chemotherapy can result in insomnia
Insomnia occurs in approximately three-quarters of cancer patients who have undergone chemotherapy....
Published Tuesday 01 December 2009
Osteoarthritis risk increased by high exercise levels
Men and women in middle age who exercise on a regular basis...
Published Monday 30 November 2009
Cancer genome changes increase cervical cancer relapse risk
Patients with cervical cancer are three to four times more likely to...
Published Sunday 29 November 2009
Number of Americans with diabetes expected to double by 2034
The number of people developing diabetes in the US is expected to...
Published Sunday 29 November 2009
H1N1 virus appears to increase asthma risk in children
Asthma is a significant risk factor in children who have contracted the...
Published Sunday 29 November 2009
New treatment could prevent thrombosis in PAD patients
Thrombosis is a common side effect in patients undergoing bypass surgery for...
Published Sunday 29 November 2009
More Medical News
Migraine sufferers at increased risk of stroke
17 Nov 2009 - Posted by the Editorial Team
Individuals who suffer from migraines are more than twice as likely to experience the most common type of stroke.
This risk is 2.3 times bigger than people who do not have migraines, meaning that sufferers are at an increased risk of having the type of stroke where blood supply to the brain is suddenly cut off due to a blood clot or the build-up of plaque.
Researchers at Johns Hopkins University, US, made the finding during a study on people between the ages of 18 and 70, none of whom had previously suffered from a stroke.
Senior study investigator Dr Saman Nazarian said that it is "crucial" to identify which people are at greater risk of stroke.
"Based on this data, physicians should consider addressing stroke risk factors in patients with a history or signs of light flashes and blurry vision associated with severe headaches," the expert explained.
According to UK organisation Migraine Action, migraines affect twice as many women as men.
Visit the Migraine Knowledge Centre
- New medication offers hope to migraine sufferers 12/08/09
- Migraine patients may benefit from surgery 31/07/09
- Link confirmed between migraines and reduced breast cancer risk 09/07/09
- Smoking can trigger migraines, Spanish study concludes 03/07/09
- Shift in focus towards treatment of migraines 28/05/09
- SANOMIGRAN
Prophylactic treatment of recurrent vascular headaches, including classical migraine , common migraine and cluster headaches (periodic migrainous neuralgia). It is not effective in relieving migraine attacks once in progress ... - TOPAMAX
... Migraine Topamax is indicated in adults for the prophylaxis of migraine headache. Initiation of treatment with topiramate should be restricted to specialist care and treatment should be managed under specialist supervision or shared care arrangements. Prophylactic treatment of migraine may be ... - MAXOLON 10mg Tablets
... Post-anaesthetic vomiting Migraine: 'Maxolon' relieves symptoms of nausea and vomiting, and overcomes gastric stasis associated with attacks of migraine. This improvement in gastric emptying assists the absorption of concurrently administered oral anti-migraine therapy (e.g. paracetamol) which may ... - IMIGRAN RECOVERY
Subcutaneous Injection is indicated for the acute relief of migraine attacks, with or without aura, and for the acute treatment of cluster headache. Imigran should only be used where there is a clear diagnosis of migraine or cluster headache ... - MIGRALEVE
Migraleve Ultra are indicated for the acute relief of migraine attacks, with or without aura. Migraleve Ultra should only be used where there is a clear diagnosis of migraine ... - IMIGRAN tablets
Imigran tablets are indicated for the acute relief of migraine attacks, with or without aura. Imigran should only be used where there is a clear diagnosis of migraine ...





